These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38678160)

  • 21. In-Silico Analysis and Protective Efficacy of the PcrV Recombinant Vaccine against Pseudomonas Aeruginosa in the Burned and PA-Infected BALB/c Mouse Model.
    Fakoor MH; Owlia P; Mousavi Gargari SL; Sabokbar A
    Iran J Immunol; 2020 Jun; 17(2):121-136. PubMed ID: 32602466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit Models.
    Le HN; Tran VG; Vu TTT; Gras E; Le VTM; Pinheiro MG; Aguiar-Alves F; Schneider-Smith E; Carter HC; Sellman BR; Stover CK; DiGiandomenico A; Diep BA
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160288
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase 1 study of MEDI3902, an investigational anti-Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults.
    Ali SO; Yu XQ; Robbie GJ; Wu Y; Shoemaker K; Yu L; DiGiandomenico A; Keller AE; Anude C; Hernandez-Illas M; Bellamy T; Falloon J; Dubovsky F; Jafri HS
    Clin Microbiol Infect; 2019 May; 25(5):629.e1-629.e6. PubMed ID: 30107283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.
    DiGiandomenico A; Warrener P; Hamilton M; Guillard S; Ravn P; Minter R; Camara MM; Venkatraman V; Macgill RS; Lin J; Wang Q; Keller AE; Bonnell JC; Tomich M; Jermutus L; McCarthy MP; Melnick DA; Suzich JA; Stover CK
    J Exp Med; 2012 Jul; 209(7):1273-87. PubMed ID: 22734046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
    Moriyama K; Wiener-Kronish JP; Sawa T
    Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies against lipopolysaccharide protect against
    Kang J; Mateu-Borrás M; Monroe HL; Sen-Kilic E; Miller SJ; Dublin SR; Huckaby AB; Yang E; Pyles GM; Nunley MA; Chapman JA; Amin MS; Damron FH; Barbier M
    Front Cell Infect Microbiol; 2023; 13():1191806. PubMed ID: 37424774
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by
    Das S; Howlader DR; Zheng Q; Ratnakaram SSK; Whittier SK; Lu T; Keith JD; Picking WD; Birket SE; Picking WL
    Front Immunol; 2020; 11():583008. PubMed ID: 33281815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous
    Liu C; Pan X; Xia B; Chen F; Jin Y; Bai F; Priebe G; Cheng Z; Jin S; Wu W
    Front Immunol; 2018; 9():1737. PubMed ID: 30093906
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel humanized anti-PcrV monoclonal antibody COT-143 protects mice from lethal
    Numata S; Hara T; Izawa M; Okuno Y; Sato Y; Yamane S; Maki H; Sato T; Yamano Y
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0069424. PubMed ID: 39269189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PcrV antibody-antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice.
    Song Y; Baer M; Srinivasan R; Lima J; Yarranton G; Bebbington C; Lynch SV
    Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1837-45. PubMed ID: 22187351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia.
    Wu W; Huang J; Duan B; Traficante DC; Hong H; Risech M; Lory S; Priebe GP
    Am J Respir Crit Care Med; 2012 Sep; 186(5):420-7. PubMed ID: 22723292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overcoming Barriers to Preventing and Treating
    Lopes JA; Rghei AD; Thompson B; Susta L; Khursigara CM; Wootton SK
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551918
    [No Abstract]   [Full Text] [Related]  

  • 33. Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.
    Neely AN; Holder IA; Wiener-Kronish JP; Sawa T
    Burns; 2005 Mar; 31(2):153-8. PubMed ID: 15683685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.
    Frank DW; Vallis A; Wiener-Kronish JP; Roy-Burman A; Spack EG; Mullaney BP; Megdoud M; Marks JD; Fritz R; Sawa T
    J Infect Dis; 2002 Jul; 186(1):64-73. PubMed ID: 12089663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice.
    Holder IA; Neely AN; Frank DW
    Infect Immun; 2001 Sep; 69(9):5908-10. PubMed ID: 11500471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antivirulence Bispecific Monoclonal Antibody-Mediated Protection against Pseudomonas aeruginosa Ventilator-Associated Pneumonia in a Rabbit Model.
    Aguiar-Alves F; Le HN; Tran VG; Gras E; Vu TTT; Dong OX; Quetz JS; Cheng LI; Yu L; Sellman BR; Stover CK; DiGiandomenico A; Diep BA
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0202221. PubMed ID: 34902264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia.
    Baker SM; Pociask D; Clements JD; McLachlan JB; Morici LA
    Vaccine; 2019 Feb; 37(6):808-816. PubMed ID: 30638799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement.
    De Tavernier E; Detalle L; Morizzo E; Roobrouck A; De Taeye S; Rieger M; Verhaeghe T; Correia A; Van Hegelsom R; Figueirido R; Noens J; Steffensen S; Stöhr T; Van de Velde W; Depla E; Dombrecht B
    J Biol Chem; 2016 Jul; 291(29):15243-55. PubMed ID: 27226529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From
    Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M
    Front Immunol; 2019; 10():2497. PubMed ID: 31708925
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model.
    Imamura Y; Yanagihara K; Fukuda Y; Kaneko Y; Seki M; Izumikawa K; Miyazaki Y; Hirakata Y; Sawa T; Wiener-Kronish JP; Kohno S
    Eur Respir J; 2007 May; 29(5):965-8. PubMed ID: 17301098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.